Oil & Gas Midstream
Compare Stocks
5 / 10Stock Comparison
GEL vs XOM vs CVX vs OXY vs SLB
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Oil & Gas Exploration & Production
Oil & Gas Equipment & Services
GEL vs XOM vs CVX vs OXY vs SLB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Midstream | Oil & Gas Integrated | Oil & Gas Integrated | Oil & Gas Exploration & Production | Oil & Gas Equipment & Services |
| Market Cap | $2.00B | $611.92B | $362.06B | $52.75B | $79.97B |
| Revenue (TTM) | $1.68B | $323.90B | $184.43B | $23.18B | $35.71B |
| Net Income (TTM) | $48M | $28.84B | $12.30B | $4.71B | $3.35B |
| Gross Margin | 16.8% | 21.7% | 30.4% | 26.2% | 18.2% |
| Operating Margin | 18.6% | 10.5% | 9.0% | 12.4% | 15.3% |
| Forward P/E | 20.7x | 14.3x | 14.7x | 11.4x | 20.3x |
| Total Debt | $3.05B | $43.54B | $46.74B | $23.96B | $12.31B |
| Cash & Equiv. | $6M | $10.68B | $6.47B | $1.99B | $3.04B |
GEL vs XOM vs CVX vs OXY vs SLB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Genesis Energy, L.P. (GEL) | 100 | 204.1 | +104.1% |
| Exxon Mobil Corpora… (XOM) | 100 | 317.6 | +217.6% |
| Chevron Corporation (CVX) | 100 | 197.9 | +97.9% |
| Occidental Petroleu… (OXY) | 100 | 409.5 | +309.5% |
| SLB N.V. (SLB) | 100 | 288.4 | +188.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GEL vs XOM vs CVX vs OXY vs SLB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GEL is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 3 yrs, beta 0.27, yield 4.0%
- Lower volatility, beta 0.27, current ratio 0.98x
- Beta 0.27, yield 4.0%, current ratio 0.98x
- Beta 0.27 vs SLB's 0.83
XOM is the clearest fit if your priority is long-term compounding.
- 102.6% 10Y total return vs CVX's 134.7%
Among these 5 stocks, CVX doesn't own a clear edge in any measured category.
OXY ranks third and is worth considering specifically for value and quality.
- Lower P/E (11.4x vs 20.3x)
- 20.3% margin vs GEL's 2.9%
SLB carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth -1.6%, EPS growth -24.4%, 3Y rev CAGR 8.3%
- -1.6% revenue growth vs GEL's -45.0%
- +58.6% vs GEL's +22.3%
- 6.5% ROA vs GEL's 1.0%, ROIC 12.1% vs 4.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -1.6% revenue growth vs GEL's -45.0% | |
| Value | Lower P/E (11.4x vs 20.3x) | |
| Quality / Margins | 20.3% margin vs GEL's 2.9% | |
| Stability / Safety | Beta 0.27 vs SLB's 0.83 | |
| Dividends | 4.0% yield, 3-year raise streak, vs XOM's 2.8% | |
| Momentum (1Y) | +58.6% vs GEL's +22.3% | |
| Efficiency (ROA) | 6.5% ROA vs GEL's 1.0%, ROIC 12.1% vs 4.0% |
GEL vs XOM vs CVX vs OXY vs SLB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GEL vs XOM vs CVX vs OXY vs SLB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OXY leads in 2 of 6 categories
SLB leads 1 • GEL leads 0 • XOM leads 0 • CVX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
OXY leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 193.0x GEL's $1.7B. OXY is the more profitable business, keeping 20.3% of every revenue dollar as net income compared to GEL's 2.9%. On growth, GEL holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.7B | $323.9B | $184.4B | $23.2B | $35.7B |
| EBITDAEarnings before interest/tax | $550M | $59.9B | $37.1B | $10.6B | $7.4B |
| Net IncomeAfter-tax profit | $48M | $28.8B | $12.3B | $4.7B | $3.4B |
| Free Cash FlowCash after capex | $209M | $23.6B | $16.2B | $3.6B | $4.8B |
| Gross MarginGross profit ÷ Revenue | +16.8% | +21.7% | +30.4% | +26.2% | +18.2% |
| Operating MarginEBIT ÷ Revenue | +18.6% | +10.5% | +9.0% | +12.4% | +15.3% |
| Net MarginNet income ÷ Revenue | +2.9% | +8.9% | +6.7% | +20.3% | +9.4% |
| FCF MarginFCF ÷ Revenue | +12.5% | +7.3% | +8.8% | +15.4% | +13.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +12.1% | -1.3% | -5.3% | -23.1% | +5.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +103.9% | -11.0% | -24.5% | +3.1% | -31.2% |
Valuation Metrics
OXY leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 21.6x trailing earnings, XOM trades at a 35% valuation discount to OXY's 32.9x P/E. On an enterprise value basis, OXY's 6.6x EV/EBITDA is more attractive than SLB's 12.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.0B | $611.9B | $362.1B | $52.7B | $80.0B |
| Enterprise ValueMkt cap + debt − cash | $5.0B | $644.8B | $402.3B | $74.7B | $89.2B |
| Trailing P/EPrice ÷ TTM EPS | -22.42x | 21.55x | 27.37x | 32.94x | 22.67x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.72x | 14.31x | 14.68x | 11.38x | 20.26x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 10.29x | 10.76x | 10.84x | 6.57x | 12.11x |
| Price / SalesMarket cap ÷ Revenue | 1.23x | 1.89x | 1.96x | 2.44x | 2.24x |
| Price / BookPrice ÷ Book value/share | 2.83x | 2.33x | 1.75x | 1.45x | 2.90x |
| Price / FCFMarket cap ÷ FCF | 22.69x | 25.92x | 21.82x | 12.85x | 16.68x |
Profitability & Efficiency
SLB leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
SLB delivers a 13.9% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $7 for CVX. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEL's 4.30x. On the Piotroski fundamental quality scale (0–9), CVX scores 5/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.2% | +10.7% | +7.2% | +12.6% | +13.9% |
| ROA (TTM)Return on assets | +1.0% | +6.4% | +4.2% | +5.6% | +6.5% |
| ROICReturn on invested capital | +4.0% | +8.6% | +6.2% | +4.7% | +12.1% |
| ROCEReturn on capital employed | +5.0% | +8.9% | +6.6% | +4.9% | +14.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 | 5 | 4 | 4 |
| Debt / EquityFinancial leverage | 4.30x | 0.16x | 0.24x | 0.65x | 0.45x |
| Net DebtTotal debt minus cash | $3.0B | $32.9B | $40.3B | $22.0B | $9.3B |
| Cash & Equiv.Liquid assets | $6M | $10.7B | $6.5B | $2.0B | $3.0B |
| Total DebtShort + long-term debt | $3.0B | $43.5B | $46.7B | $24.0B | $12.3B |
| Interest CoverageEBIT ÷ Interest expense | 1.97x | 69.44x | 17.22x | 3.25x | 9.40x |
Total Returns (Dividends Reinvested)
Evenly matched — GEL and SLB each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XOM five years ago would be worth $26,064 today (with dividends reinvested), compared to $18,283 for SLB. Over the past 12 months, SLB leads with a +58.6% total return vs GEL's +22.3%. The 3-year compound annual growth rate (CAGR) favors GEL at 22.9% vs OXY's -1.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +5.4% | +18.6% | +17.5% | +25.7% | +33.2% |
| 1-Year ReturnPast 12 months | +22.3% | +39.9% | +37.4% | +30.3% | +58.6% |
| 3-Year ReturnCumulative with dividends | +85.8% | +43.0% | +26.0% | -5.6% | +21.3% |
| 5-Year ReturnCumulative with dividends | +102.8% | +160.6% | +93.8% | +111.8% | +82.8% |
| 10-Year ReturnCumulative with dividends | -8.7% | +102.6% | +134.7% | -8.9% | -8.9% |
| CAGR (3Y)Annualised 3-year return | +22.9% | +12.7% | +8.0% | -1.9% | +6.7% |
Risk & Volatility
Evenly matched — OXY and SLB each lead in 1 of 2 comparable metrics.
Risk & Volatility
OXY is the less volatile stock with a -0.25 beta — it tends to amplify market swings less than SLB's 0.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SLB currently trades 93.1% from its 52-week high vs OXY's 78.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.27x | -0.20x | -0.11x | -0.25x | 0.83x |
| 52-Week HighHighest price in past year | $18.64 | $176.41 | $214.71 | $67.45 | $57.20 |
| 52-Week LowLowest price in past year | $13.21 | $101.19 | $133.77 | $39.26 | $31.64 |
| % of 52W HighCurrent price vs 52-week peak | +87.8% | +81.8% | +84.5% | +78.6% | +93.1% |
| RSI (14)Momentum oscillator 0–100 | 36.6 | 39.5 | 39.2 | 39.1 | 47.7 |
| Avg Volume (50D)Average daily shares traded | 251K | 18.9M | 11.0M | 17.2M | 16.2M |
Analyst Outlook
Evenly matched — GEL and XOM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GEL as "Buy", XOM as "Hold", CVX as "Buy", OXY as "Buy", SLB as "Buy". Consensus price targets imply 22.2% upside for GEL (target: $20) vs 7.4% for CVX (target: $195). For income investors, GEL offers the higher dividend yield at 4.03% vs SLB's 2.02%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $20.00 | $161.08 | $194.87 | $60.08 | $58.66 |
| # AnalystsCovering analysts | 16 | 55 | 53 | 52 | 66 |
| Dividend YieldAnnual dividend ÷ price | +4.0% | +2.8% | +3.8% | +3.0% | +2.0% |
| Dividend StreakConsecutive years of raises | 3 | 26 | 8 | 4 | 4 |
| Dividend / ShareAnnual DPS | $0.66 | $4.00 | $6.87 | $1.59 | $1.08 |
| Buyback YieldShare repurchases ÷ mkt cap | +13.1% | +3.3% | +3.3% | 0.0% | +3.0% |
OXY leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). SLB leads in 1 (Profitability & Efficiency). 3 tied.
GEL vs XOM vs CVX vs OXY vs SLB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GEL or XOM or CVX or OXY or SLB a better buy right now?
For growth investors, SLB N.
V. (SLB) is the stronger pick with -1. 6% revenue growth year-over-year, versus -45. 0% for Genesis Energy, L. P. (GEL). Exxon Mobil Corporation (XOM) offers the better valuation at 21. 6x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate Genesis Energy, L. P. (GEL) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GEL or XOM or CVX or OXY or SLB?
On trailing P/E, Exxon Mobil Corporation (XOM) is the cheapest at 21.
6x versus Occidental Petroleum Corporation at 32. 9x. On forward P/E, Occidental Petroleum Corporation is actually cheaper at 11. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — GEL or XOM or CVX or OXY or SLB?
Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +160.
6%, compared to +82. 8% for SLB N. V. (SLB). Over 10 years, the gap is even starker: CVX returned +134. 7% versus OXY's -8. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GEL or XOM or CVX or OXY or SLB?
By beta (market sensitivity over 5 years), Occidental Petroleum Corporation (OXY) is the lower-risk stock at -0.
25β versus SLB N. V. 's 0. 83β — meaning SLB is approximately -430% more volatile than OXY relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 4% for Genesis Energy, L. P. — giving it more financial flexibility in a downturn.
05Which is growing faster — GEL or XOM or CVX or OXY or SLB?
By revenue growth (latest reported year), SLB N.
V. (SLB) is pulling ahead at -1. 6% versus -45. 0% for Genesis Energy, L. P. (GEL). On earnings-per-share growth, the picture is similar: Genesis Energy, L. P. grew EPS 41. 1% year-over-year, compared to -34. 0% for Occidental Petroleum Corporation. Over a 3-year CAGR, SLB leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GEL or XOM or CVX or OXY or SLB?
Occidental Petroleum Corporation (OXY) is the more profitable company, earning 11.
0% net margin versus -0. 5% for Genesis Energy, L. P. — meaning it keeps 11. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OXY leads at 17. 2% versus 9. 0% for CVX. At the gross margin level — before operating expenses — OXY leads at 33. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GEL or XOM or CVX or OXY or SLB more undervalued right now?
On forward earnings alone, Occidental Petroleum Corporation (OXY) trades at 11.
4x forward P/E versus 20. 7x for Genesis Energy, L. P. — 9. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GEL: 22. 2% to $20. 00.
08Which pays a better dividend — GEL or XOM or CVX or OXY or SLB?
All stocks in this comparison pay dividends.
Genesis Energy, L. P. (GEL) offers the highest yield at 4. 0%, versus 2. 0% for SLB N. V. (SLB).
09Is GEL or XOM or CVX or OXY or SLB better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20), 2. 8% yield, +102. 6% 10Y return). Both have compounded well over 10 years (XOM: +102. 6%, SLB: -8. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GEL and XOM and CVX and OXY and SLB?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GEL is a small-cap income-oriented stock; XOM is a large-cap quality compounder stock; CVX is a large-cap income-oriented stock; OXY is a mid-cap income-oriented stock; SLB is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.